SRRM1 and nasopharyngeal carcinoma: Expression of SRRM1(+) promoted the proliferation of nasopharyngeal carcinoma cells HONE1 and 6–10B, and had no significant effect on gastric carcinoma cells AGS, comparing to the control group (oe‐NC).